tm logo
BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV
Live/Pending
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER

record initialized not assigned to examiner

on 05 Mar 2024

Last Applicant/ Owned by

2 Gansevoort Street, 9th Floor

New York

NY

10014

Serial Number

98433749 filed on 05th Mar 2024

Registration Number

N/A

Correspondent Address

Maury M. Tepper, III Tepper & Eyster, PLLC

3724 Benson Drive

Raleigh, NC 27609

United States

Filing Basis

1. filed as use application

2. use application currently

Disclaimer

NO DATA

BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV

The wording BRIUMVI has no meaning in a foreign language. "150 MG/6ML INJECTION FOR IV" Providing health information The color(s) black, dark grey, light blue and gold is/are claimed as a feature of the mark. The mark consists of the text "BRIUMVI" in black above the text "UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV" in dark grey with the "B" in "BRIUMVI" partially surrounded by a light blue Read More

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


Providing health information


First Use Date in General

28th Dec 2022

First Use Date in Commerce

28th Dec 2022

Mark Details


Serial Number

No 98433749

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Description of Design Search

The mark consists of the text "BRIUMVI" in black above the text "UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV" in dark grey with the "B" in "BRIUMVI" partially surrounded by a light blue sphere edged in gold.

Legal History


Status DateAction Taken
05th Mar 2024NEW APPLICATION ENTERED